Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C

doi:10.4254/wjh.v9.i8.436

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9549)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

554

WORD

229

HTML

3812

Figures (1-2)

162

Tables (1-2)

146

Sum=4903

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

454

Download

1085

Sum=1539

Publishing Process of This Article

Item

Count

Browse

1187

Download

1920

Sum=3107

Mar 18, 2017 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Mar 18, 2017; 9(8): 436-442
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.436

Table 1 Demographic, laboratory and liver fibrosis characteristics

Characteristics	Patients (n = 81)
Gender (male/female)	40 (49.4%)/41 (50.6%)
Age (yr) - median (Q1;Q3)	51 (30-78)
BMI (kg/m²) - median (Q1;Q3)	26.5 (24.3-29.6)
ALT (IU/L) - median (Q1;Q3)	50 (32.5-85)
AST (IU /L) - median (Q1;Q3)	42 (28.5-61.5)
Platelet count (× 10³/mm³) - median (Q1; Q3)	202 (148-247)
Histological fibrosis stage, n (%)
F0	5 (6.2)
F1	33 (40.7)
F2	20 (24.7)
F3	12 (14.8)
F4	11 (13.6)
TE (kPa) - median (Q1; Q3)	6.9 (5-12.2)
TE success rate (mean ± SD)	0.92 ± 0.21
CAP (dB/m) - mMedian (Q1; Q3)	237 (204-263)
ARFI (m/s) - median (Q1; Q3)	1.25 (0.65-2.89)
APRI - median (Q1; Q3)	0.66 (0.41-1.29)
FIB-4 - median (Q1; Q3)	1.41 (0.90-2.45)

BMI: Body mass index; ALT: Alanine amino transferase; AST: Aspartate amino transferase; TE: Transient elastography; CAP: Controlled attenuation parameter; ARFI: Acoustic radiation force impulse; APRI: Score index (AST/LSN AST/platelet); FIB-4: Score index (age × AST/platelet × ALT).

Citation: Paranaguá-Vezozzo DC, Andrade A, Mazo DFC, Nunes V, Guedes AL, Ragazzo TG, Moutinho R, Nacif LS, Ono SK, Alves VAF, Carrilho FJ. Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C. World J Hepatol 2017; 9(8): 436-442
URL: https://www.wjgnet.com/1948-5182/full/v9/i8/436.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i8.436